UiPath Inc. (NYSE:PATH) Shares Bought by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc raised its position in UiPath Inc. (NYSE:PATH) by 2.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,878 shares of the healthcare company’s stock after acquiring an additional 4,550 shares during the quarter. Ensign Peak Advisors Inc’s holdings in UiPath were worth $2,522,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. ORG Partners LLC grew its position in shares of UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after buying an additional 1,112 shares in the last quarter. Hantz Financial Services Inc. acquired a new position in shares of UiPath during the second quarter worth about $28,000. Redwood Wealth Management Group LLC acquired a new position in shares of UiPath during the second quarter worth about $43,000. Lindbrook Capital LLC grew its position in shares of UiPath by 46.0% during the first quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after buying an additional 639 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of UiPath by 40.2% during the first quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after buying an additional 632 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the sale, the chief financial officer now owns 849,917 shares in the company, valued at $10,258,498.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 22.37% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on PATH. Wells Fargo & Company boosted their price objective on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. BMO Capital Markets upped their price target on UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a report on Friday, September 6th. TD Cowen lowered their price target on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a report on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Friday, September 6th. Finally, Evercore ISI upped their price target on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $17.71.

UiPath Trading Up 1.6 %

Shares of NYSE PATH opened at $12.80 on Friday. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The stock has a 50 day moving average of $12.16 and a two-hundred day moving average of $15.56. The stock has a market cap of $7.33 billion, a P/E ratio of -79.97 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business had revenue of $316.00 million during the quarter, compared to analysts’ expectations of $303.69 million. During the same quarter in the prior year, the business earned ($0.09) earnings per share. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. As a group, research analysts predict that UiPath Inc. will post -0.23 earnings per share for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.